Silver Book Fact

Deep Brain Stimulation for Parkinson’s Adds QALYs and Saves Money

Fact image

Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States. Neuromodulation. 2016; 19(7). https://onlinelibrary.wiley.com/doi/abs/10.1111/ner.12474

Reference

Title
Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States
Publication
Neuromodulation
Publication Date
2016
Volume & Issue
Volume 19, Issue 7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value

Related Facts

  • A clinical trial in Europe found that treating Alzheimer’s patients with an Alzheimer’s drug reduced annual treatment costs by $1,000 per patient.  
  • Slowing the Progress of Parkinson’s Disease Would Save Money
     
  • Galantamine, a cholinesterase inhibitor, delays Alzheimer’s patients’ need for full-time care, with overall cost savings estimated between $323 and $4,256 per patient.  
  • Around 75 – 100 experimental therapies that are aimed at slowing or stopping the progression of Alzheimer’s disease are currently in clinical trials.  
  • “If you or a loved one started exhibiting symptoms of Alzheimer’s disease 12 years ago, there were no medicines for you to take. All you could do was hope–that…